Azienda Ospedaliero-Universitaria San Luigi Gonzaga

Torino 10043

1 studies enrolling now · 2 studies all time

What they study most

Locally Advanced or Metastatic Unresectable Urothelial Cancer, NSCLC

Studies at this site

• A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies — Recruiting now
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed